Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New market for Mivacron

Jan. 21, 1997

New 5-HT1A receptor ligands reported by Bayer

Jan. 21, 1997

Sumitomo reports novel hCNTF variant

Jan. 21, 1997

Merck & Co. claims NMDA and AMPA antagonists for neurologic indications

Jan. 21, 1997

New anticonvulsants from Howard University

Jan. 21, 1997

BMS antidepressant chosen for important multiinstitutional trial

Jan. 20, 1997

Phase II trials begin on ICOS MS treatment

Jan. 20, 1997

Conclusion of Cephalon/Schering-Plough AD collaboration

Jan. 17, 1997

Novel antioxidant disclosed by Nippon Chemiphar

Jan. 17, 1997

Japanese investigators isolate novel aminopeptidase inhibitor

Jan. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...